Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients

Transplant International

Volumn 12, Issue 4, 1999, Pages 254-260

  Wreghitt, Tim G ^a   Abel, Simon J C ^b   McNeil, Keith ^b   Parameshwar, Jayan ^b   Stewart, Susan ^b   Cary, Nat ^b   Sharples, Linda ^b   Large, Stephen ^b   Wallwork, John ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Cytomegalovirus; Ganciclovir; Heart transplantation; Heart lung transplantation; Lung transplantation; Prophylaxis

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH CARE POLICY; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0032864280     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050219     Document Type: Article

References (12)

1. Balfour HH, Chace BA, Stapleton JT, Simmons RL, Fryd DS (1989) Randomized, placebo-controlled trial of oral aciclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320: 1381-1387
2. Bradstreet CMP, Taylor CED (1962) Technique of complement fixation test applicable to the diagnosis of virus diseases. Mon Bull Minist Health Public Health Lab Serv 21: 96-104
3. Collaborative DHPG Treatment Study Group (1986) Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies. N Engl J Med 314: 801-805
4. Goodrich JM, Mori M, Gleaves CA, DuMond C, Cays M, Ebeling DF, Buhles WC, DeAmond B, Meyers JD (1991) Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 325: 1601-1607
5. Gray JJ, Alvey B, Smith DJ, Wreghitt TG (1987) Evaluation of a commercial latex agglutination test for detecting antibodies to cytomegalovirus in organ donors and transplant recipients. J Virol Methods 16:13-19
6. Griffiths PD, Panjwani DD, Stirk PR, Ball MG, Ganczakowski H, Blacklock HA, Prentice HG (1984) Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet 2: 1242-1245
7. Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovek RM, Richenbacker RE, Millar RC, DuMond C, DeAmond B, Sullivan V, Chenery T, Buhles W, Stinson EB (1992) A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 326: 1182-1186
8. Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA, and the City of Hope-Stanford-Syntex CMV study group (1991) A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 324: 1005-1011
9. Winston DJ, Wirin D, Shaked A, Busuttil RW (1995) Randomised comparison of ganciclovir and high dose aciclovir for long-term cytomegalovirus prophylaxis in liver transplant recipients. Lancet 346: 69-74
10. Wreghitt TG (1993) Cytomegalovirus infections in heart and heart-lung transplant recipients. In: Rose ML, Yacoub MH (eds) Immunology of heart and lung transplantation. Edward Arnold, London, pp 232-242
11. Wreghitt TG, Gray JJ, Chandler C (1986) Prognostic value of cytomegalovirus IgM antibody in transplant recipients. Lancet 1: 1157-1158
12. Wreghitt TG, Hakim M, Gray JJ, Kucia S, Wallwork J, English TAH (1988) Cytomegalovirus infections in heart and heart and lung transplant recipients. J Clin Pathol 41: 660-667